share_log

艾伯维的帕金森病药物在后期试验中达到主要目标

Gelonghui Finance ·  Sep 26 10:50

格隆汇9月26日|艾伯维公司周四公布,Tavapadon在治疗早期帕金森病患者的关键3期临床试验中达到主要终点。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment